Provider roles in the recruitment of underrepresented populations to cancer clinical trials (Q36698291)

15 August 2017

0 references

Provider roles in the recruitment of underrepresented populations to cancer clinical trials (English)

1 reference

15 August 2017

11

Eric B Bass

1 reference

15 August 2017

Mollie W Howerton

1

1 reference

15 August 2017

M Chris Gibbons

2

1 reference

15 August 2017

Charles R Baffi

3

1 reference

15 August 2017

Tiffany L Gary

4

1 reference

15 August 2017

Gabriel Y Lai

5

1 reference

15 August 2017

Shari Bolen

6

1 reference

15 August 2017

Jon Tilburt

7

1 reference

15 August 2017

Teerath Peter Tanpitukpongse

8

1 reference

15 August 2017

Renee F Wilson

9

1 reference

15 August 2017

Neil R Powe

10

1 reference

15 August 2017

Jean G Ford

12

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

15 August 2017

1 reference

15 August 2017

109

1 reference

15 August 2017

3

1 reference

15 August 2017

465-476

1 reference

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials

15 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Selection and description of cancer clinical trials participants--science or happenstance?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Grading quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Clinicians' attitudes to clinical trials of cancer therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Factors that influence Spanish- and English-speaking participants' decision to enroll in cancer randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Barriers to clinical trial participation by older women with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Participation of Asian-American women in cancer chemoprevention research: physician perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Clinical trial enrollment of rural patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

To refer or not to refer: Factors that affect primary care provider referral of patients with cancer to clinical treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Entry into clinical trials in breast cancer: the importance of specialist teams. Scottish Breast Cancer Focus Group and Scottish Cancer Therapy Network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22436

7 January 2021

Identifiers

DOI

10.1002/CNCR.22436

1 reference

15 August 2017

1 reference